Landry Robert E

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
2 Feb 24	REGN Regeneron Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	956.65	281	268.82 k	23,693
2 Feb 24	REGN Regeneron Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	378.98	400	151.59 k	23,974
2 Feb 24	REGN Regeneron Pharmaceuticals	NQSO Common Stock	Option exercise	Dispose M	No	No	378.98	400	151.59 k	11,787
31 Jan 24	REGN Regeneron Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	953.42	282	268.86 k	23,574
31 Jan 24	REGN Regeneron Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	378.98	400	151.59 k	23,856
31 Jan 24	REGN Regeneron Pharmaceuticals	NQSO Common Stock	Option exercise	Dispose M	No	No	378.98	400	151.59 k	12,187
24 Jan 24	REGN Regeneron Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	951.26	352	334.84 k	23,456
24 Jan 24	REGN Regeneron Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	378.98	500	189.49 k	23,808
24 Jan 24	REGN Regeneron Pharmaceuticals	NQSO Common Stock	Option exercise	Dispose M	No	No	378.98	500	189.49 k	12,587
23 Jan 24	REGN Regeneron Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	948.5	776	736.04 k	23,308

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.